What is the appropriate management for a newborn at 37 weeks gestation whose mother is hepatitis B surface antigen (HBsAg) positive?

Management of Newborn at 37 Weeks Gestation Born to HBsAg-Positive Mother

All infants born to HBsAg-positive mothers must receive both hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of birth, administered at separate anatomical sites (e.g., different limbs). 1

Immediate Birth Management (Within 12 Hours)

Immunoprophylaxis Administration

• Administer single-antigen hepatitis B vaccine (not combination vaccines like Pediarix) 1
• Administer HBIG simultaneously at a different injection site 1
• Timing is critical: Both must be given within 12 hours of birth to maximize protection 1, 2

Weight-Based Considerations

Since this is a 37-week infant (likely ≥2,000g):

• Count the birth dose as dose #1 of the vaccine series 1
• Complete the series with doses at 1-2 months and 6 months 1
• Final dose must not be given before 24 weeks (164 days) of age 1

Important caveat: If the infant weighs <2,000g, the birth dose does NOT count toward the series—give 4 total doses (birth dose plus 3 additional doses starting at 1 month) 1

Vaccine Series Completion

Follow this schedule for infants ≥2,000g:

• Dose 1: Birth (within 12 hours) ✓
• Dose 2: 1-2 months of age
• Dose 3: 6 months of age (not before 24 weeks/164 days) 1

Mandatory Post-Vaccination Testing (9-12 Months)

All infants born to HBsAg-positive mothers require serologic testing at 9-12 months of age (typically at the next well-child visit after completing the vaccine series) 1

Testing Protocol

Test for:

• Anti-HBs (hepatitis B surface antibody)
• HBsAg (hepatitis B surface antigen)

Do NOT test before 9 months—this avoids detecting passive antibodies from the HBIG given at birth 1

Interpretation and Management

If HBsAg-negative and anti-HBs ≥10 mIU/mL:

• Infant is protected
• No further management needed 1

If HBsAg-negative but anti-HBs <10 mIU/mL:

• Give one additional vaccine dose immediately
• Retest 1-2 months later 1
• If still <10 mIU/mL after single dose, complete a second full 3-dose series
• Retest 1-2 months after final dose 1

If HBsAg-positive:

• Infant has acquired HBV infection despite prophylaxis (occurs in ~1% of cases) 3
• Refer immediately for pediatric hepatology follow-up 1

Breastfeeding Guidance

Breastfeeding is safe and should not be discouraged once the infant has received immunoprophylaxis at birth 4, 1, 2

The 2023 EASL guidelines note the only contraindications are cracked nipples with detectable maternal HBV DNA or infant oral ulcers 4

Delivery and Intrapartum Considerations

Cesarean section is NOT recommended solely to reduce HBV transmission—delivery mode should be based only on obstetric indications 4, 2

The exception noted in EASL guidelines: cesarean may be considered only for Asian HBeAg-positive women with very high HBV DNA (>7 log₁₀ copies/ml) who did not receive antiviral therapy during pregnancy 4

Common Pitfalls to Avoid

1. Delayed administration: Giving vaccine/HBIG after 12 hours significantly reduces efficacy
2. Using combination vaccines at birth: Only single-antigen HepB vaccine should be used for the birth dose 1
3. Same injection site: HBIG and vaccine must be given at separate anatomical sites 1
4. Early serologic testing: Testing before 9 months will detect passive HBIG antibodies, not true vaccine response 1
5. Forgetting the final dose timing: Never give the last dose before 24 weeks of age 1
6. Missing post-vaccination testing: This is mandatory for all infants born to HBsAg-positive mothers to identify the ~1% who become infected despite prophylaxis 3

Facility Transfer Communication

If the infant is transferred to another facility (e.g., NICU), ensure clear documentation and communication about vaccine and HBIG administration status to prevent missed or duplicate doses 1